Category: Diseases & Conditions
Diseases & Conditions market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Tuberculosis Therapeutics
The 2025-2030 World Outlook for Tuberculosis Therapeutics This study covers the world outlook for tuberculosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Gout Therapeutics
The 2025-2030 World Outlook for Gout Therapeutics This study covers the world outlook for gout therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies This study covers the world outlook for breast cancer diagnostics and drug technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care
The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care This study covers the world outlook for granulocyte colony stimulating factor (g-CSF) cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent ... Read More
-
The 2025-2030 World Outlook for Hemophilia Gene Therapies
The 2025-2030 World Outlook for Hemophilia Gene Therapies This study covers the world outlook for hemophilia gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Therapeutics
The 2025-2030 World Outlook for Hepatitis C Therapeutics This study covers the world outlook for hepatitis c therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Hepatitis Test Solution-Diagnosis
The 2025-2030 World Outlook for Hepatitis Test Solution-Diagnosis This study covers the world outlook for hepatitis test solution-diagnosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Online Sales of Diabetic Shoes
The 2025-2030 World Outlook for Online Sales of Diabetic Shoes This study covers the world outlook for online sales of diabetic shoes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Bisphosphonates
The 2025-2030 World Outlook for Bisphosphonates This study covers the world outlook for bisphosphonates across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Therapeutics
The 2025-2030 World Outlook for Hepatitis B Therapeutics This study covers the world outlook for hepatitis b therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Testing-Screening
The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Therapeutics
The 2025-2030 World Outlook for Cancer Therapeutics This study covers the world outlook for cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Pancreatic Cancer Drugs This study covers the world outlook for pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Allergy Diagnostics and Therapeutics
The 2025-2030 World Outlook for Allergy Diagnostics and Therapeutics This study covers the world outlook for allergy diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Cold Pain Therapies
The 2025-2030 World Outlook for Cold Pain Therapies This study covers the world outlook for cold pain therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Drugs
The 2025-2030 World Outlook for Immunotherapy Drugs This study covers the world outlook for immunotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Sexually Transmitted Disease Therapeutics
The 2025-2030 World Outlook for Sexually Transmitted Disease Therapeutics This study covers the world outlook for sexually transmitted disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Medical Marijuana
The 2025-2030 World Outlook for Medical Marijuana This study covers the world outlook for medical marijuana across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Pandemic Infectious Disease Products
The 2025-2030 World Outlook for Pandemic Infectious Disease Products This study covers the world outlook for pandemic infectious disease products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for NSCLC Therapeutics
The 2025-2030 World Outlook for NSCLC Therapeutics This study covers the world outlook for NSCLC therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Immune Thrombocytopenia
The 2025-2030 World Outlook for Immune Thrombocytopenia This study covers the world outlook for immune thrombocytopenia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Hydroxyurea Sickle Cell Disease Treatments
The 2025-2030 World Outlook for Hydroxyurea Sickle Cell Disease Treatments This study covers the world outlook for hydroxyurea sickle cell disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancers
The 2025-2030 World Outlook for Colorectal Cancers This study covers the world outlook for colorectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Postoperative Pain Therapeutics
The 2025-2030 World Outlook for Postoperative Pain Therapeutics This study covers the world outlook for postoperative pain therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
Research Assistance
